Advertisement
PerkinElmer
PerkinElmer

The Scientist

» FDA, evolution and culture

Most Recent

image: Behavior Brief

Behavior Brief

By | April 8, 2015

A round-up of recent discoveries in behavior research

0 Comments

image: ALS Drug Access Debated

ALS Drug Access Debated

By | April 7, 2015

Biotech company Genervon has requested accelerated approval for its experimental ALS drug after a small but promising Phase 2 trial. Patients advocate for its acceptance, while researchers urge caution.

2 Comments

image: Book Excerpt from <em>p53</em>

Book Excerpt from p53

By | April 1, 2015

In Chapter 12, "Of Mice and Men," author Sue Armstrong recounts the point at which researchers moved from working with p53 in tissue culture to studying the gene in animal models.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | April 1, 2015

Junk DNA, Cuckoo, Sapiens, and Cool

0 Comments

image: Setbacks and Great Leaps

Setbacks and Great Leaps

By | April 1, 2015

The tale of p53, a widely studied tumor suppressor gene, illustrates the inventiveness of researchers who turn mishaps into discoveries.

1 Comment

image: Ebola Mutation Rate Quibble

Ebola Mutation Rate Quibble

By | March 27, 2015

A study suggests that the virus may not be evolving as quickly as a previous group estimated.

0 Comments

image: FDA Deems GM Apples, Potatoes Safe

FDA Deems GM Apples, Potatoes Safe

By | March 23, 2015

Genetically modified, non-browning apples and bruise-resistant potatoes are safe, the US Food and Drug Administration says.

0 Comments

image: The 2015 Salary Survey Is Complete

The 2015 Salary Survey Is Complete

By | March 13, 2015

Thanks to everyone who participated in this year's survey. Please check back in November for the results.

0 Comments

image: Book Excerpt from <em>Galileo’s Middle Finger</em>

Book Excerpt from Galileo’s Middle Finger

By | March 10, 2015

In Chapter 4, “A Show-Me State of Mind,” author Alice Dreger describes the start of her journey studying scientists who had conducted controversial research.

1 Comment

image: FDA OKs First Biosimilar

FDA OKs First Biosimilar

By | March 6, 2015

The US Food and Drug Administration approves Sandoz’s Zarxio, a biosimilar to Amgen’s filgrastim, which is mainly prescribed for cancer patients.

2 Comments

Advertisement

Popular Now

  1. When Does a Smart Mouse Become Human?
  2. Most Earth-like Planet Found
  3. The Lies That Scars Tell
    Notebook The Lies That Scars Tell

    Macaque trainers in Bangladesh are often bitten by their monkeys, but rarely infected by a particular simian retrovirus.

  4. AAAAA Is for Arrested Translation
Advertisement
The Scientist